ArticleFrontiers in oncology2022

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO.

Serena Di Cosimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.